Osteopore Ltd. (OSX) Price & Analysis

Q: What is Osteopore Ltd.’s market cap?

Osteopore Ltd.’s market cap is AU$1.91M.

Q: When is Osteopore Ltd.’s upcoming earnings report date?

Osteopore Ltd.’s upcoming earnings report date is Feb 27, 2026 which is in 70 days.

Q: How were Osteopore Ltd.’s earnings last quarter?

Osteopore Ltd. released its earnings results on Aug 29, 2025. The company reported -AU$0.009 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.009.

Q: Is Osteopore Ltd. overvalued?

According to Wall Street analysts Osteopore Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Q: Does Osteopore Ltd. pay dividends?

Osteopore Ltd. does not currently pay dividends.

Q: What is Osteopore Ltd.’s EPS estimate?

Osteopore Ltd.’s EPS estimate for its next earnings report is not yet available.

Q: How many shares outstanding does Osteopore Ltd. have?

Osteopore Ltd. has 272,501,800 shares outstanding.

Q: What happened to Osteopore Ltd.’s price movement after its last earnings report?

Osteopore Ltd. reported an EPS of -AU$0.009 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.

Q: Which hedge fund is a major shareholder of Osteopore Ltd.?

Currently, no hedge funds are holding shares in AU:OSX

Compare

9 Followers

OSX Stock Chart & Stats

AU$0.01

AU$0.00(0.00%)

At close: Jan 09 4:00 PM EST

AU$0.01

AU$0.00(0.00%)

Day’s Range― - ―

52-Week Range<AU$0.01 - AU$0.05

Previous CloseN/A

Volume70.28K

Average Volume (3M)2.16M

Market Cap

AU$1.91M

Enterprise ValueAU$381.76K

Total Cash (Recent Filing)AU$1.81M

Total Debt (Recent Filing)AU$1.68M

Price to Earnings (P/E)―

Beta4.50

Next Earnings

Feb 27, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)>-0.01

Shares Outstanding272,501,800

10 Day Avg. Volume675,672

30 Day Avg. Volume2,156,422

Financial Highlights & Ratios

PEG Ratio0.02

Price to Book (P/B)8.95

Price to Sales (P/S)0.97

P/FCF Ratio-0.88

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusHold

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Osteopore Ltd. News

Osteopore Ltd. Announces Quotation of New Securities on ASX

Osteopore Ltd. ( ($AU:OSX) ) has shared an announcement. Osteopore Ltd. has announced the quotation of 16,949,152 new...

7d ago

OSX

Osteopore Ltd. Issues New Convertible Notes to Bolster Growth

Osteopore Ltd. ( ($AU:OSX) ) has issued an update. Osteopore Ltd. announced the issuance of new unquoted convertible...

24d ago

OSX

Osteopore Ltd. Advances Funding with Convertible Notes Issuance

An update from Osteopore Ltd. ( ($AU:OSX) ) is now available. Osteopore Ltd. has issued a Cleansing Notice...

24d ago

OSX

Osteopore Secures Additional Funding to Advance Regenerative Medicine Solutions

Osteopore Ltd. ( ($AU:OSX) ) has provided an announcement. Osteopore Limited has announced a further drawdown of its...

24d ago

OSX

Osteopore Ltd. Expands Market Presence with New Securities Quotation

The latest update is out from Osteopore Ltd. ( ($AU:OSX) ). Osteopore Ltd. has announced the quotation of...

29d ago

OSX

Osteopore Ltd. Announces Change in Substantial Holding

Osteopore Ltd. ( ($AU:OSX) ) has shared an announcement. Osteopore Ltd. has announced that Advance Opportunities Fund I...

1M ago

OSX

Osteopore Ltd. Announces Cessation of Securities

The latest update is out from Osteopore Ltd. ( ($AU:OSX) ). Osteopore Ltd. announced the cessation of 12,500...

2M ago

OSX

Osteopore Reports Revenue Growth and Swiss Market Approval

Osteopore Ltd. ( ($AU:OSX) ) has issued an announcement. Osteopore Limited reported a revenue of AUD 812K for...

2M ago

OSX

Osteopore Partners with Tan Tock Seng Hospital for AVN Implant Development

The latest update is out from Osteopore Ltd. ( ($AU:OSX) ). Osteopore Limited has announced a collaboration with...

3M ago

OSX

Osteopore Expands into Cellular Regenerative Medicine with OsteoRx Launch

Osteopore Ltd. ( ($AU:OSX) ) just unveiled an update. Osteopore Limited has launched OsteoRx, a special purpose vehicle...

4M ago

OSX

OSX FAQ

What was Osteopore Ltd.’s price range in the past 12 months?

Osteopore Ltd. lowest share price was <AU$0.01 and its highest was AU$0.05 in the past 12 months.

What is Osteopore Ltd.’s market cap?

Osteopore Ltd.’s market cap is AU$1.91M.

When is Osteopore Ltd.’s upcoming earnings report date?

Osteopore Ltd.’s upcoming earnings report date is Feb 27, 2026 which is in 70 days.

How were Osteopore Ltd.’s earnings last quarter?

Osteopore Ltd. released its earnings results on Aug 29, 2025. The company reported -AU$0.009 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.009.

Is Osteopore Ltd. overvalued?

According to Wall Street analysts Osteopore Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Osteopore Ltd. pay dividends?

Osteopore Ltd. does not currently pay dividends.

What is Osteopore Ltd.’s EPS estimate?

Osteopore Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Osteopore Ltd. have?

Osteopore Ltd. has 272,501,800 shares outstanding.

What happened to Osteopore Ltd.’s price movement after its last earnings report?

Osteopore Ltd. reported an EPS of -AU$0.009 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Osteopore Ltd.?

Currently, no hedge funds are holding shares in AU:OSX

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Osteopore Ltd. Stock Smart Score

Underperform

Fundamentals

Return on Equity

-487.52%

Trailing 12-Months

Asset Growth

-7.78%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Osteopore Ltd.

Osteopore Limited designs, develops, and markets bioresorbable polymer implants for neurosurgical, orthopedic, and maxillofacial surgery applications in Singapore, Australia, and internationally. Its technology fabricates specific micro-structured scaffolds for bone regeneration through 3D printing and bioresorbable material. The company offers Osteoplug, a bioresorbable implant, which is used for covering trephination burr holes in neurosurgery; and Osteomesh, a bioresorbable implant that is used in craniofacial surgery to repair various types of fractures, such as orbital floor fracture, as well as to fill surgical defects. Osteopore Limited has a collaboration agreement with Livingstone Health Holding Limited to jointly develop new applications and products for regenerating bone and tissue. The company was incorporated in 2003 and is headquartered in Singapore.